![](images/graphics/blank.gif)
Abiraterone acetate plus prednisone
-
To assess the efficacies and potential predictors of a corticosteroid switch in metastatic castrationresistant prostate cancer (mCRPC) patients with biochemical progression on abiraterone acetate plus prednisone (A + P).
9p
vimahuateng
26-11-2021
3
1
Download
-
With the recent introduction of novel treatment options, real-world data from patients with metastatic castration-resistant prostate cancer (mCRPC) are required to better understand the impact on routine clinical practice.
12p
viputrajaya2711
22-06-2020
6
0
Download
-
Testosterone suppression is the standard treatment for advanced prostate cancer, and it is associated with side-effects that impair patients’ quality of life, like sexual dysfunction, osteoporosis, weight gain, and increased cardiovascular risk.
8p
vikuala271
13-06-2020
9
1
Download
-
To describe the patterns of second-line treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) after docetaxel treatment in a Spanish population, to identify the factors associated with those patterns, and to compare the efficacy and safety of the treatments most frequently administered.
10p
vikuala271
13-06-2020
15
0
Download
CHỦ ĐỀ BẠN MUỐN TÌM
![](images/graphics/blank.gif)